Enanta Pharmaceuticals Inc (NASDAQ:ENTA)

36.88
Delayed Data
As of Feb 26
 +0.72 / +1.99%
Today’s Change
31.22
Today|||52-Week Range
52.58
-27.47%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Enanta Pharmaceuticals Inc have a median target of 41.50, with a high estimate of 47.00 and a low estimate of 40.00. The median estimate represents a +12.53% increase from the last price of 36.88.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in Enanta Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$1.69
Sales
$59.3M
Reporting Date
May 06

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -22.50%
 
 
 
 
 
 
Growthannually 279.74%
 
 
 
 
 

Sales

Growthquarterly -23.50%
 
 
 
 
 
 
Growthannually 356.29%
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account